KRT14 and colitis: To evaluate whether the absence of inducible nonhematopoietic MHCII expression (shown below) alters susceptibility to bacterial-driven colitis, pIV−/− K14 CIITA Tg mice and heterozygous controls chronically infected since birth with H. hepaticus were treated with anti-IL-10R mAb.